40 related articles for article (PubMed ID: 38555622)
1. Impact of Risk Stratification in Patients With Diabetes Mellitus in a Health System Specialty Pharmacy Setting.
Stout M; Giavatto C; McDonald N; Bryant L; Ross C; Fitzpatrick C; Mourani J; Lopez-Medina AI
J Pharm Pract; 2024 May; ():8971900241257293. PubMed ID: 38809250
[No Abstract] [Full Text] [Related]
2. "That's a tricky one": Access to misoprostol for early pregnancy loss in retail pharmacies across Arizona.
Lee H; Morikawa K; Gotwalt J; Kerwin R; Tschann M; Bullock H
Contraception; 2024 May; ():110507. PubMed ID: 38806140
[TBL] [Abstract][Full Text] [Related]
3. Specialty Pharmacy Services: Preparing for a New Era in Health-System Pharmacy.
Shay B; Louden L; Kirschenbaum B
Hosp Pharm; 2015 Oct; 50(9):834-9. PubMed ID: 26912924
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to Evaluating the impact of an interdisciplinary integrated limb preservation service operating concurrently with a single-specialty service.
J Foot Ankle Res; 2024 Jun; 17(2):e12026. PubMed ID: 38807295
[No Abstract] [Full Text] [Related]
5. Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Hanson RL; Habibi M; Khamo N; Abdou S; Stubbings J
Am J Health Syst Pharm; 2014 Mar; 71(6):463-9. PubMed ID: 24589537
[TBL] [Abstract][Full Text] [Related]
6. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
[TBL] [Abstract][Full Text] [Related]
7. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
[No Abstract] [Full Text] [Related]
8. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
9. Health-system specialty pharmacy role and outcomes: A review of current literature.
Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
[TBL] [Abstract][Full Text] [Related]
10. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
[No Abstract] [Full Text] [Related]
11. Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.
Petry L; Zuckerman AD; DeClercq J; Choi L; Lynch B; Saknini M
J Manag Care Spec Pharm; 2023 Jul; 29(7):732-739. PubMed ID: 37404072
[No Abstract] [Full Text] [Related]
12. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
[No Abstract] [Full Text] [Related]
13. Specialty drug coverage varies between health plans' medical and pharmacy benefit policies.
Levine AA; Panzer AD; Kauf TL; O'Sullivan AK; Strand L; Chambers JD
J Manag Care Spec Pharm; 2023 Jun; 29(6):607-613. PubMed ID: 37276044
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
